Maternal RSV vaccine cuts infant hospitalizations by 70%, study shows

Article excerpt

A University of Pittsburgh study published in JAMA Network Open found that vaccinating pregnant women against respiratory syncytial virus (RSV) reduced hospitalizations in infants under one year old by nearly 70%. The virus, which causes severe respiratory infections in young children, sends thousands of babies to hospitals annually. The research suggests maternal vaccination during pregnancy provides significant protection to newborns during their most vulnerable months, before they can receive vaccines themselves. This finding could reshape how doctors approach RSV prevention in infancy.